Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $117
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo has maintained an Equal-Weight rating on Zimmer Biomet Holdings and raised the price target from $110 to $117.
October 31, 2024 | 7:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Zimmer Biomet Holdings and increased the price target from $110 to $117, indicating a positive outlook.
The increase in price target from $110 to $117 by Wells Fargo suggests a positive outlook for Zimmer Biomet Holdings. Maintaining an Equal-Weight rating indicates that the stock is expected to perform in line with the market. The raised price target is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100